Ovarian function in patients with systemic lupus erythematosus: Pathogenesis, drug application and prospective therapies

doi:10.5493/wjem.v14.i2.88867

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (272)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

126

Figures (1-1)

Sum=161

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=91

Publishing Process of This Article

Item

Count

Browse

Download

Sum=15

Jun 20, 2024 (publication date) through Jun 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Exp Med. Jun 20, 2024; 14(2): 88867
Published online Jun 20, 2024. doi: 10.5493/wjem.v14.i2.88867

Open in New Tab Full Size Figure Download Figure

Figure 1 Umbilical cord mesenchymal stem cell (UC-MSC) transplantation reduced ovarian fibrosis in MRL/Lpr (MRL/Mpj-Faslpr/J, #000485, The Jackon Laboratories, United States) mice. A: Representative masson staining of ovaries from MRL/Lpr mice in the PBS group; B: Representative masson staining of ovaries from MRL/Lpr mice in the umbilical cord mesenchymal stem cell transplantation group. Magnification: 40 × (top) and 100 × (bottom).

Citation: Xu M, Tian LL, Li XL, Bao C, Zhang HW, Chen HW. Ovarian function in patients with systemic lupus erythematosus: Pathogenesis, drug application and prospective therapies. World J Exp Med 2024; 14(2): 88867
URL: https://www.wjgnet.com/2220-315x/full/v14/i2/88867.htm
DOI: https://dx.doi.org/10.5493/wjem.v14.i2.88867